PAVmed (PAVM) EPS (Diluted) Growth (1y) (2017 - 2026)
PAVmed (PAVM) EPS (Diluted) Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 13.96% |
| 10 | PAVmed | 32.44 Mn | 28.66 Mn | -89,000.00 | -18.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 96.04% |
| Dec 31, 2025 | -548.04% |
| Jun 30, 2025 | 38.25% |
| Mar 31, 2025 | 112.86% |
| Dec 31, 2024 | 100.94% |
| Jun 30, 2024 | 43.26% |
| Mar 31, 2024 | 5.78% |
| Dec 31, 2023 | 36.39% |
| Sep 30, 2023 | 45.68% |
| Jun 30, 2023 | 52.43% |
| Mar 31, 2023 | 85.80% |
| Dec 31, 2022 | 82.70% |
| Sep 30, 2022 | 69.20% |
| Jun 30, 2022 | 66.93% |
| Mar 31, 2022 | -78.20% |
| Dec 31, 2021 | -96.15% |
| Sep 30, 2021 | -121.23% |
| Jun 30, 2021 | -104.37% |
| Mar 31, 2021 | 34.64% |
| Dec 31, 2020 | -39.58% |